NCTN Deep South Research Consortium

NCTN 深南研究联盟

• 批准号: 10301677
• 负责人: MARY-ANN BJORNSTI
• 金额: $ 2.5万
• 依托单位: UNIVERSITY OF ALABAMA AT BIRMINGHAM
• 依托单位国家: 美国
• 财政年份: 2020
• 资助国家: 美国
• 起止时间: 2020-11-18 至 2021-02-28
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/10301677
• 关键词: Alabama; American College of Radiology Imaging Network; Area; Cancer Biology; Cancer Patient; Cancer and Leukemia Group B; Clinical Investigator; Clinical Research; Clinical Trials; Clinical Trials Cooperative Group; Comprehensive Cancer Center; Cooperative Group Program; Deep South; Eastern Cooperative Oncology Group; Ensure; Gynecologic Oncology Group; Infrastructure; Intention; Investigational Therapies; Lead; Leadership; Malignant Neoplasms; Mentors; Minority; National Clinical Trials Network; National Surgical Adjuvant Breast and Bowel Project; Patients; Process; Radiation Therapy Oncology Group; Recording of previous events; Research; Research Personnel; Site; Socioeconomic Status; Southwest Oncology Group; Translational Research; United States; Universities; Vision; cancer risk; clinical trial participant; demographics; interest; member; next generation; organizational structure; patient population; population based; programs; recruit; translational scientist

The University of Alabama at Birmingham Comprehensive Cancer Center (UAB CCC) has a long history of participation within the nation's cancer related Clinical Trials Cooperative Group Program. Specifically, UAB was a founding member of the GOG, and has been a member of RTOG, ECOG, ACRIN. CALGB, NSABP, and SWOG. UAB CCC is a current member of the ALLIANCE, ECOG-ACRIN, NRG and SWOG cooperative groups. The UAB NCTN Deep South Research Consortium (DSRC) is currently a Lead Academic Participating Site in the NCI's National Clinical Trials Network (NCTN) Program, and now submits this proposal to continue to serve the NCI in this capacity. It is our intention to continue as a leading contributor of scientific leaders and clinical trial participants to the NCTN Program in the U.S. and particularly in the Southeast. To accomplish this overall vision, we propose the following specific aims: 1) To further enhance the involvement of existing UAB CCC scientific leadership in NCTN Cooperative Group related clinical and translational research and to develop the next generation of NCTN Cooperative group scientific leaders within the UAB CCC, and 2) To further refine a clinical trials process within the DSRC that optimizes accrual of potentially eligible cancer patients and patients at risk for cancer to NCTN Cooperative Group clinical trials, and 3) To further increase minority accrual to NCTN Cooperative Group trials. We include in this proposal a detailed description of our DSRC cooperative group scientific and patient accrual contributions and accomplishments, a leadership and organizational structure for our Consortium, and how we intend to utilize existing DSRC infrastructure to achieve our aims. Further, we also include a detailed description of our Junior Investigator Recruitment and Mentoring Program.

阿拉巴马大学伯明翰综合癌症中心（UAB CCC）有着悠久的历史